Professor Paul Digard has been Head of the Infection & Immunity Division at The Roslin Institute, University of Edinburgh since 2014. His laboratory is interested in understanding virus replication, pathogenesis and host range. He has led many translational studies on antiviral drug development and virus control measures and published extensively on herpesviruses, plus strand RNA viruses and influenza A virus. Before working at The Roslin Institute, he was a senior lecturer at the University of Cambridge and a Research Fellow at Harvard Medical School, USA.
Scientist: Paul Digard
Covid-19: Boosting antiviral research
As countries around the world implement national pandemic plans, we take a look at some of the research strategies being pursued to tackle Covid-19.
A scientist’s opinion : Interview with Professor Paul Digard on research efforts to develop treatments against Covid-19
Research efforts to develop treatments against Covid-19 Professor Paul Digard, virologist at The Roslin Institute, University of Edinburgh, tells us about potential routes to Covid-19 treatment and the prospect of having to deal with the virus long-term. How soon do you think a vaccine against Covid-19 will be available? Paul Digard: I can’t see a ...
